NCT03022032View on ClinicalTrials.gov

The HOPE Trial and the SMART Study

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

April 12, 2017

Primary Completion Date

September 2, 2020

Study Completion Date

September 2, 2020

Conditions
Gynecologic Cancer
Interventions
DEVICE

Fitbit Zip

Fitbit Zip

OTHER

HOPE App

HOPE App

OTHER

Standard of Care

Standard of Care

DEVICE

Fitbit Charge 2

Fitbit Charge 2

OTHER

SMART Study Intervention

SMART study app + Beiwe study app + Fitbit

Trial Locations (1)

02115

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Institute of Nursing Research (NINR)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT03022032 - The HOPE Trial and the SMART Study | Biotech Hunter | Biotech Hunter